About Us
dr Kees Baggerman
Kees Baggerman, founder of Baggerman Farma Consult, began his career with a short period as an industrial pharmacist. He the went on to work as a hospital pharmacist until 1987. In 1986 he obtained his Ph.D. degree at Leyden University for his thesis related to pharmaceutical technology. He then started his pioneering work as an independent consultant in the field of pharmaceutical production and regulatory affairs. Since then he supported numerous companies with all kinds of regulatory and quality issues, got involved in a wide variety of developmental projects, ran various projects in over 30 hospital pharmacies, served for many years as an evaluation expert in various EU research programs, acted as secretary of a federation of pharmaceutical SME’s for over 10 years, and published over 30 articles and reports on various pharmaceutical issues and developments.
drs Wout Jan Louwaars
Wout Jan Louwaars, graduated as a pharmacist from the University of Utrecht in 1978. He began his career as an industrial pharmacist at the Central Military Pharmacy, before moving on to Chefaro International holding the position of Head of R&D and later Head of QA/QC. In 1996 he joined Baggerman Farma Consult and has since worked on projects aimed at the implementation of GMP/GDP, FDA/GcLP and ISO 9000/13485 for various pharmaceutical, chemical and medical device companies. He has also been responsible for a number of (European) regulatory projects for drugs, blood products and medical devices. He has been acting Qualified Person for a number of (bio)pharmaceutical companies in recent years.
drs Jens-Erik Vaessen
Jens-Erik Vaessen was engaged in a research project at the Analytical Department of Novo-Nordisk Denmark while being a pharmacy student at the University of Groningen. After his graduation in 1999 he started as a community pharmacist for a short period of time and then moved on to a phytopharma-ceutical company. In 2000 he joined Baggerman Farma Consult and since he held various positions on regulatory affairs departments and in manufacturing plants as production pharmacist or Qualified Person. Other projects included the development and implementation of various quality systems (GDP, GMP) in several companies (food, cosmetics, pharmaceuticals). He also has been engaged in complex compliance projects in the area of the Code of Conduct for Pharmaceutical Advertising (CGR).
drs Chantal Ruijl-Vandierendonck
Chantal Ruijl-Vandierendonck completed her pharmacy study in 1991. She has worked for many years as an auditor in the Quality Assurance department of a Clinical Research Organization (CRO) and got very familiar with GCP, GMP, GDP and EN 540 systems. At the same time she was responsible for the storage and packaging of investigational medicinal products. She joined Baggerman Farma Consult in 2002 and acts as responsible pharmacist (QP) for several pharmaceutical distributors and packers. She also worked on projects regarding design and implementation of quality systems (GDP and GMP) as well as executing clinical research projects and various regulatory projects.
drs Harald Kistemaker
Harald Kistemaker studied pharmacy at the University of Utrecht. After a short period in hospital pharmacy he entered into 10 years of experience in the pharmaceutical industry, starting as an industrial pharmacist at the International Dispensary Association. In 2000 he became QA manager at TEVA Pharmaceutical Industries and later on worked for Sandoz as Head of QA & RA. During these years he became very familiar with GMP, GDP and GcLP as well as auditing these quality systems at all kinds of (non-)European manufacturers. In 2005 he joined Baggerman Farma Consult and currently acts as a Qualified Person for several pharmaceutical companies while holding RA-responsibility for others. He also is involved in releasing and auditing of investigational medicinal products imported from 3rd countries.
drs Ivan Utama
Ivan Utama studied bio-pharmaceutical sciences at Leiden University, graduating in 2000. He subsequently specialized in analytical biosciences performing research for a couple of years on the development of analytical techniques for the characterization of lipoproteins in plasma. In 2005 he switched to another discipline and joined Baggerman Farma Consult. Since then, his main focus has been on regulatory affairs and he has managed several extensive projects in major pharmaceutical companies, including a European parenteral manufacturing site as well as a leading OTC-company in Belgium.
ir Maria Caspers-van Acker
Maria Caspers-van Acker studied food technology at Wageningen Agricultural University and graduated in 1991. After being a QA-manager in the food business for 5 years, she became lead-auditor at a certification and consultancy agency (BVQI) and performed audits on quality systems (ISO9001), food-safety (HACCP, BRC, IFS) and medical related systems (HKZ, NEN 46000) as well as in manufacturing and logistic services organisations .
In 2005 she switched to Sanquin, the national blood supply foundation in The Netherlands, to perform internal (ISO9001 and GMP) and supplier audits. In 2007 she joined Baggerman Farma Consult to do consultancy on quality related food-issues in pharmacy (e.g. supplements, vitamins) and GDP in logistic services. Besides this, she focusses on Regulatory Affairs.
